Patients with X-linked inhibitor of apoptosis (XIAP) deficiency present with a primary immunodeficiency characterized by hemophagocytic lymphohistiocytosis, severe infections, splenomegaly, and cytopenia (113, 158, 159). Here, XIAP is linked to infection.